We believe the life-changing benefits of genomics should be available to the many, not the few. Guided by our Mission, we are taking action through our business strategy to Expand Access to Genomics, Empower our Communities, Integrate Environmental Sustainability, Nurture our People, and Operate Responsibly. We are working to expand access by enabling innovation and driving affordability, by broadening the reach of the genomic ecosystem, and ensuring equitable access with representative data to drive greater health equity. This past year the world crossed a significant milestone for genomic testing, with over one billion people across 45 countries reimbursed for genomic tests, cancer therapy selection, genetic disease diagnosis, and non-invasive prenatal testing. We aim to reach two billion covered lives by 2026. Through innovation and investments in R&D, we are unlocking new possibilities for clinicians to power personalized medicine, improve patient outcomes, and drive down overall healthcare costs.